NCT00410878View on ClinicalTrials.gov

A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic Pain

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

Not specified

Study Completion Date

August 31, 1999

Conditions
PainAnalgesics, Opioid
Interventions
DRUG

OROS Hydromorphone HCI (slow release)

All Listed Sponsors
lead

Alza Corporation, DE, USA

INDUSTRY

NCT00410878 - A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic Pain | Biotech Hunter | Biotech Hunter